Wedlund P J, Chang S L, Levy R H
J Pharm Sci. 1983 Aug;72(8):860-2. doi: 10.1002/jps.2600720806.
A steady-state approach is proposed to examine the contribution that the lung makes to the total body elimination of medium- to high-clearance drugs. Carbamazepine, a potential candidate of pulmonary metabolism, was investigated by infusion into the femoral vein in seven unrestrained Sprague-Dawley rats (250-300 g). Blood samples (0.45 ml), taken simultaneously from the jugular vein and carotid artery in each rat during the infusion (2-5 days), were assayed in duplicate for carbamazepine by GLC/CI/MS. Venous blood concentrations were used to calculate the total body clearance of carbamazepine, 440 +/- 38 ml/hr (mean +/- SEM), and the difference between simultaneous venous and arterial blood concentrations were used to calculate the extraction ratio of carbamazepine by the lung. The mean extraction ratio of 0.0058 (n = 28) suggests that the lung only contributes approximately 5% to the total body clearance of carbamazepine. It is proposed that this technique could be useful in examining the importance of the lung in the total body clearance of other drugs, and that it has several advantages over some currently used techniques.
提出了一种稳态方法来研究肺对中高清除率药物全身清除的贡献。通过向7只无约束的Sprague-Dawley大鼠(250 - 300克)股静脉注射,对潜在的肺代谢候选药物卡马西平进行了研究。在输注期间(2 - 5天),从每只大鼠的颈静脉和颈动脉同时采集血样(0.45毫升),采用气相色谱/化学电离/质谱法对卡马西平进行双份测定。用静脉血浓度计算卡马西平的全身清除率,为440±38毫升/小时(平均值±标准误),同时用静脉血和动脉血浓度之差计算肺对卡马西平的提取率。平均提取率为0.0058(n = 28),表明肺对卡马西平全身清除的贡献仅约为5%。有人提出,该技术可用于研究肺在其他药物全身清除中的重要性,并且与目前使用的一些技术相比具有若干优势。